🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of telitac...
Status
Terminated
Location
Anniston, Alabama Site
Start Date
2022-06-20
Trial ID
NCT05306574
Treatments Being Tested
This study is a prospective, open-labelled, randomized, controlled, single-...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-06-29
Trial ID
NCT05962840
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of subcuta...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2023-04-06
Trial ID
NCT05673993
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Telitac...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2023-04-28
Trial ID
NCT05799287
Treatments Being Tested
This single-center, prospective, single-arm study will evaluate the efficac...
Status
Active Not Recruiting
Location
Peking University First Hospital, Renal Division
Start Date
2025-07-12
Trial ID
NCT07111338
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of telitac...
Status
Withdrawn
Location
Hemet site
Start Date
2024-09
Trial ID
NCT06456567
Treatments Being Tested
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM...
Status
Recruiting
Location
Arizona Arthritis & Rheumatology Associates P.C.
Start Date
2026-02-26
Trial ID
NCT07404865
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of telitacicept in pa...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05929248
Treatments Being Tested
This is a Phase III, multicenter, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Beijing Hospital
Start Date
2026-01-13
Trial ID
NCT07249632
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled single-center ...
Status
Recruiting
Location
Ren Ji Hospital
Start Date
2024-06-28
Trial ID
NCT06394063
Treatments Being Tested